MENU

ONCY Oncolytics Biotech Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products for the treatment of cancers

Industry Biotechnology
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ONCY is expected to report earnings to fall 2.42% to -11 cents per share on March 06

Oncolytics Biotech ONCY Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.10
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.10
The last earnings report on November 12 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 721.33K shares outstanding, the current market capitalization sits at 59.24M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for the treatment of cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
322 11th Avenue S.W
Phone
+1 403 670-7377
Employees
26
Web
https://www.oncolyticsbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ONCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-6.55%
SRRK - ONCY
39%
Loosely correlated
+1.82%
RIGL - ONCY
33%
Poorly correlated
-3.61%
ABCL - ONCY
29%
Poorly correlated
-2.45%
RCUS - ONCY
28%
Poorly correlated
-2.60%
DNA - ONCY
27%
Poorly correlated
+1.91%
More